CCA
DXCM icon

Childress Capital Advisors’s DexCom DXCM Stock Holding History

Childress Capital Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,488
Closed -$206K – 226
2024
Q1 		$206K Buy
+1,488
New +$187K 0.06% 202
2023
Q1 		– Sell
-2,112
Closed -$239K – 113
2022
Q4 		$239K Buy
+2,112
New +$232K 0.08% 157
2021
Q1 		– Sell
-1,244
Closed -$114K – 390
2020
Q4 		$114K Buy
+1,244
New +$111K 0.07% 138

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Childress Capital Advisors's DXCM Position: Q2 2024 in Review

Childress Capital Advisors sold out of DexCom (DXCM) in Q2 2024, closing a stake of 1,488 shares — an estimated $206K sold.

Childress Capital Advisors first reported a position in DXCM in Q4 2020 and held it in 3 quarters. The position peaked at $239K in Q4 2022. 999 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • Childress Capital Advisors reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • Childress Capital Advisors sold 1,488 DexCom shares in Q2 2024, an estimated $206K.
  • Childress Capital Advisors first reported a position in DexCom in Q4 2020 and held it in 3 quarters.
  • Childress Capital Advisors's DexCom position peaked at $239K in Q4 2022.
  • 999 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Childress Capital Advisors's 13F filing for Q2 2024, filed 5 Aug 2024.